Healthy-aging supplements are sold on enhancement: sharper, younger, better. The two long trials that actually recruited older adults describe something else. In the 49-week lion's mane study, the statistically significant deterioration happened in the placebo group. In the 16-week study, the gains vanished four weeks after people stopped taking it. That's not enhancement — it's losing ground more slowly, for as long as you keep paying.
Lion's mane is the only species with long trials in older adults. Mori 2009 gave 30 people aged 50 to 80 with mild cognitive impairment 3 grams a day for 16 weeks; scores rose at weeks 8, 12 and 16, then fell significantly four weeks after stopping. Li 2020 ran 49 weeks of erinacine A-enriched mycelium in mild Alzheimer's, where MMSE improved in the treatment arm while the placebo arm's screening scores significantly declined. Tremella, the species sold hardest on anti-aging, has one oral RCT — measuring HbA1c, which moved 0.07 percentage points. And in 30,378 NHANES participants, mushroom eating and all-cause mortality came back non-significant (HR 0.84, 95% CI 0.67–1.06).
The evidence here is thinner than the category implies and shaped differently from how it's sold. Both facts matter for what you should expect.
Which Mushroom Has Trials in Older Adults?
Lion's mane, and it's the only one. Mori's 2009 trial recruited Japanese men and women aged 50 to 80 with diagnosed mild cognitive impairment. Thirty subjects were randomised into two groups of fifteen, and the treatment arm took four 250 mg tablets of 96% dry powder three times daily — 3 grams a day — for 16 weeks.
Cognitive scores rose significantly against placebo at weeks 8, 12 and 16, increasing with duration of intake. No adverse effects appeared in laboratory testing.
Fifteen people per arm is a small trial, and worth saying plainly before anyone builds a decade-long habit on it.
What Happened When They Stopped?
The gains went away. Four weeks after the 16-week intake ended, the treatment group's scores had decreased significantly. Mori's team reported that as part of the result, not a footnote.
So whatever lion's mane did, it didn't leave a durable structural change behind. The effect is maintenance-dependent, which turns a supplement decision into an indefinite one.
What Did the 49-Week Study Actually Show?
Something more interesting than the usual summary. Li's 2020 trial gave patients with mild Alzheimer's three 350 mg capsules daily of erinacine A-enriched Hericium erinaceus mycelium, standardised at 5 mg/g erinacine A, for 49 weeks against identical placebo.
Read the results carefully. A significant decrease in Cognitive Abilities Screening Instrument score was noted in the placebo group. A significant improvement in Mini-Mental State Examination score was observed in the treatment group. There was a significant between-group difference in Instrumental Activities of Daily Living, and better contrast sensitivity in the treatment arm.
The placebo group also showed significant declines in calcium, albumin, apolipoprotein E4, haemoglobin and brain-derived neurotrophic factor, alongside rises in alpha1-antichymotrypsin and amyloid-beta 1-40.
That pattern is deceleration. Part of the treatment effect is the placebo group getting worse, which is a real and valuable thing for a supplement to do — and a different claim from making a healthy person better. Our Alzheimer's article covers that trial in more depth.
Where Does Tremella Fit?
Not where it's sold. Tremella is marketed as the anti-aging mushroom on the strength of its hyaluronic-acid comparison and skin hydration story — and that hydration evidence is topical, applied to skin, not swallowed.
Its only oral randomised trial measured something else entirely. Gitsomboon's 2024 study gave 56 overweight or obese prediabetic participants a Tremella fuciformis beverage or placebo daily for 12 weeks. HbA1c moved from 6.03% to 5.96% (p = 0.047, Cohen's d 0.39) and waist circumference from 95.2 to 93.46 cm (p = 0.022, d 0.45). No adverse events.
Those are small effects on metabolic endpoints in a metabolic population. A 0.07 percentage-point HbA1c change is not a longevity result, and our tremella and hyaluronic acid article is honest about where the skin evidence actually comes from.
Does Eating Mushrooms Help You Live Longer?
The largest test says probably a little, and not significantly. Ba's 2021 analysis followed 30,378 NHANES participants for a mean of 6.7 years, recording 2,855 deaths, and found a non-significant association between mushroom consumption and all-cause mortality — adjusted hazard ratio 0.84, 95% confidence interval 0.67 to 1.06.
The point estimate leans favourable and the interval crosses one. That's the honest state of the longevity premise underneath this entire product category: suggestive, unproven, and about culinary mushrooms rather than extracts.
The Ranking
| Mushroom | Best evidence in aging | Effect shape | Verdict |
|---|---|---|---|
| Lion's mane | 16-week MCI trial (n=30) and 49-week Alzheimer's trial | Deceleration; reverses on stopping | The only real candidate |
| Reishi | Fatigue −28.3% vs −20.1% in 132 patients | Symptomatic | Useful for how you feel, not how you age |
| Tremella | One oral RCT: HbA1c −0.07 pp, waist −1.7 cm | Small metabolic | Marketed far ahead of its evidence |
| Shiitake | Immune markers in healthy young adults | Immunological | Wrong population for an aging claim |
| Cordyceps | Metabolic threshold in adults aged 50–75 | Aerobic threshold | Fitness, not aging |
| Chaga, Trametes | None relevant | — | No basis |
Why "Antioxidant" Is the Wrong Frame Here
Because none of the trials above measured an antioxidant outcome, and the ones that succeeded measured cognition and daily function instead. Antioxidant capacity is a test-tube property that has repeatedly failed to predict clinical benefit — which is why the USDA withdrew its own ORAC database.
Notice what that does to the shelf. The species with the best aging evidence, lion's mane, isn't sold on antioxidants at all. The ones sold hardest on antioxidants, chaga and tremella, have no aging trials. The marketing frame and the evidence are pointing at different products.
What Would You Actually Do?
- If you want the species with trials in your age group, that's lion's mane. Both studies recruited older adults; nothing else in the category did.
- Match a trial dose. Mori used 3 grams a day of dried fruiting body; Li used 1,050 mg a day of mycelium standardised to 5 mg/g erinacine A. Those are different materials, per our fruiting body versus mycelium article.
- Expect to keep taking it. Mori's gains reversed within four weeks of stopping, so budget for an indefinite habit rather than a course.
- Don't buy tremella for aging. Buy it if you like it as food, or use it topically where the hydration evidence actually is.
- Eat mushrooms as food too. The mortality signal, weak as it is, came from dietary intake rather than capsules.
- Fix sleep and fatigue first. Reishi's result there is stronger than anything in this category's aging column — see our stress and cortisol ranking.
The Honest Summary
One species, two trials, one of them with fifteen people per arm, both in populations with existing impairment, and an effect that stops when you do. That's the real evidentiary base for mushrooms and healthy aging.
It's not nothing — a 49-week randomised trial showing preserved daily function is a genuinely good result, and rare in this field. It's just a much narrower claim than "anti-aging", and nobody has tested any of it in a healthy 55-year-old who simply wants to stay sharp.
Frequently Asked Questions
What is the best mushroom for healthy aging?
Lion's mane, because it's the only species with long randomised trials in older adults — 16 weeks in mild cognitive impairment aged 50 to 80, and 49 weeks in mild Alzheimer's. Both recruited people with existing impairment rather than healthy adults.
Do you have to keep taking lion's mane?
The evidence says yes. In Mori's trial, cognitive scores rose at weeks 8, 12 and 16, then decreased significantly four weeks after the intake stopped. The benefit appears maintenance-dependent rather than a lasting structural change.
Is tremella good for anti-aging?
Its skin evidence is topical, not oral. The only oral randomised trial measured HbA1c, which fell 0.07 percentage points (p = 0.047), and waist circumference, down 1.7 cm, in 56 prediabetic participants over 12 weeks.
Does eating mushrooms extend life?
Not on the strongest available test. Across 30,378 NHANES participants and 2,855 deaths over a mean 6.7 years, the association with all-cause mortality was non-significant — hazard ratio 0.84 with a confidence interval of 0.67 to 1.06.
How much lion's mane should an older adult take?
Mori's trial used 3 grams daily of dried fruiting body; Li's used 1,050 mg daily of erinacine A-standardised mycelium. Those aren't interchangeable materials, so pick one and match its own trial rather than averaging the numbers.
Shop Healthy Aging
Dried lion's mane (100 g €39, 500 g €169) is the cheapest way to Mori's 3 g daily dose. Lion's mane capsules (120 caps €49) hold 0.5 g each, so six reach that figure — the recommended 3–4 is a maintenance intake. Reishi capsules (120 caps €39) address fatigue, which has better data than anything in the aging column. Tremella (50 g €39, 100 g €74) is worth buying as food, not as an anti-aging claim. Free shipping on orders over €50.
Related Articles
- Lion's Mane and Longevity
- Lion's Mane and Alzheimer's Disease
- Lion's Mane and NGF: The Human Research
- Lion's Mane Dosage Guide
- Tremella and Anti-Aging
- Tremella vs Hyaluronic Acid
- Best Mushrooms for Focus and Concentration
Sources
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. PubMed 18844328
- Li IC, Chang HH, Lin CH, et al. Prevention of early Alzheimer's disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Front Aging Neurosci. 2020;12:155. PubMed 32581767
- Gitsomboon S, Ratanapornsompong G, Ongphiphadhanakul B, et al. Tremella fuciformis beverage improves glycated hemoglobin A1c and waist circumference in overweight/obese prediabetic subjects: a randomized controlled trial. BMC Nutr. 2024;10:44. PubMed 38439104
- Ba DM, Gao X, Al-Shaar L, et al. Prospective study of dietary mushroom intake and risk of mortality: results from continuous National Health and Nutrition Examination Survey (NHANES) 2003-2014 and a meta-analysis. Nutr J. 2021;20(1):80. PubMed 34548082
- Tang W, Gao Y, Chen G, et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food. 2005;8(1):53-58. PubMed 15857210